| Not Yet Recruiting | An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease i Chikungunya Virus | Phase 3 | 2026-05-01 |
| Active Not Recruiting | Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells Monkeypox (Mpox) | Phase 2 | 2025-10-27 |
| Recruiting | A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. Chikungunya Virus | Phase 3 | 2025-06-05 |
| Active Not Recruiting | A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine Encephalitis | Phase 2 | 2025-03-10 |
| Active Not Recruiting | Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Tha Monkeypox (Mpox) | Phase 2 | 2024-10-21 |
| Active Not Recruiting | Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination Chikungunya Virus Infection | Phase 3 | 2023-08-30 |
| Completed | ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 COVID-19 Disease | Phase 3 | 2022-08-30 |
| Completed | Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years Chikungunya Virus | Phase 3 | 2022-05-12 |
| Terminated | MVA-BN-RSV Vaccine Trial Respiratory Syncytial Virus Infections | Phase 3 | 2022-04-19 |
| Completed | A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine Chikungunya Virus | Phase 2 | 2021-10-11 |
| Completed | A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) Chikungunya Virus | Phase 3 | 2021-09-29 |
| Completed | ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects COVID-19 Disease | Phase 2 | 2021-08-19 |
| Completed | Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults RSV Infection | Phase 2 | 2021-02-22 |
| Completed | TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer Chordoma, HER2-positive Breast Cancer | Phase 1 | 2020-08-10 |
| Completed | A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Solid Metastatic Tumor | Phase 1 | 2020-01-08 |
| Completed | Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) Chikungunya | Phase 2 | 2019-11-20 |
| Completed | Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects Equine Encephalitis | Phase 1 | 2019-10-07 |
| Completed | Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial Smallpox | Phase 3 | 2019-06-19 |
| Completed | BN Brachyury and Radiation in Chordoma Chordoma | Phase 2 | 2018-10-31 |
| Completed | CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer Bladder Cancer | Phase 2 | 2018-09-18 |
| Completed | Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults Chikungunya Virus Infection | Phase 2 | 2018-04-18 |
| Completed | Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) Safety Issues | Phase 1 | 2018-01-08 |
| Completed | VAXCHORA Pediatric Study to Assess Safety and Immunogenicity Cholera (Disorder) | Phase 4 | 2017-07-21 |
| Completed | A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2016-12-01 |
| Completed | RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults Respiratory Syncytial Virus Infections | Phase 2 | 2016-09-01 |
| Withdrawn | RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults. Respiratory Syncytial Virus Infections | Phase 1 | 2016-09-01 |
| Completed | Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers Typhoid Fever | — | 2015-08-26 |
| Completed | Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine Respiratory Syncytial Virus Infections | Phase 1 | 2015-08-01 |
| Completed | A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® 18-42 Year Old Healthy Vaccinia-naïve Subjects | Phase 3 | 2015-03-01 |
| Completed | A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults Cholera | Phase 3 | 2014-05-01 |
| Completed | A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults Cholera | Phase 3 | 2014-05-01 |
| Completed | Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Im Smallpox | Phase 2 | 2014-04-28 |
| Completed | Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera Cholera | Phase 3 | 2013-09-01 |
| Completed | A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vacc Smallpox | Phase 2 | 2013-03-01 |
| Completed | A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smal Smallpox | Phase 3 | 2013-02-01 |
| Completed | Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Cholera | Phase 1 | 2012-04-01 |
| Completed | A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Mini Prostate Cancer Metastatic | Phase 3 | 2011-11-28 |
| Completed | A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy Breast Cancer | Phase 1 | 2010-06-01 |
| Completed | Special Access Program IMVAMUNE® Vaccination | Phase 4 | 2010-04-22 |
| Completed | Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Childr Measles | Phase 2 | 2009-06-01 |
| Completed | A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Smallpox | Phase 2 | 2009-06-01 |
| Completed | An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Tw Smallpox | Phase 2 | 2008-08-01 |
| Completed | Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects HIV Infections | Phase 1 | 2008-05-01 |
| Completed | A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer Androgen-insensitive Prostate Cancer | Phase 1 | 2008-03-01 |
| Completed | A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer Breast Cancer | Phase 1 | 2007-06-01 |
| Completed | Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection HIV Infections | Phase 1 / Phase 2 | 2007-01-01 |
| Completed | Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infecti HIV Infections | Phase 1 | 2006-10-01 |
| Completed | A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Atopic Dermatitis | Phase 2 | 2006-07-01 |
| Completed | Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients HIV Infections | Phase 2 | 2006-06-01 |
| Completed | A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallp Smallpox | Phase 2 | 2006-04-01 |
| Completed | Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients HIV Infections | Phase 1 / Phase 2 | 2005-07-01 |
| Completed | An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients HIV Infection | Phase 2 | 2005-04-01 |
| Completed | Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorder Dermatitis, Atopic, Hay Fever | Phase 1 | 2004-04-01 |
| Completed | PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy Prostate Cancer | Phase 2 | 2003-11-01 |
| Completed | Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects Smallpox | Phase 1 | 2003-09-01 |
| Completed | Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Smallpox | Phase 2 | 2003-04-01 |
| Completed | Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects Smallpox | Phase 1 | 2001-04-01 |